Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10,781,082
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
122,153
-
Shares change
-
+122,153
-
Total reported value, excl. options
-
$1,551,000
-
Value change
-
+$1,551,000
-
Number of buys
-
5
-
Price
-
$12.39
Significant Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q2 2020
5 filings reported holding LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share as of Q2 2020.
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122,153 shares
of 10,781,082 outstanding shares and own 1.1% of the company stock.
Largest 5 shareholders include ZEKE CAPITAL ADVISORS, LLC (119,750 shares), UBS Group AG (1,533 shares), tru Independence LLC (500 shares), US BANCORP \DE\ (200 shares), and Tower Research Capital LLC (TRC) (170 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.